These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 24611055)

  • 1. Involvement of gap junction channels in the pathophysiology of migraine with aura.
    Sarrouilhe D; Dejean C; Mesnil M
    Front Physiol; 2014; 5():78. PubMed ID: 24611055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Gap junctional intercellular communication: a new mechanism in pathophysiology of migraine with aura. Therapeutic applications].
    Sarrouilhe D; Dejean C
    Pathol Biol (Paris); 2012 Dec; 60(6):392-8. PubMed ID: 22633071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurological mechanisms of migraine: potential of the gap-junction modulator tonabersat in prevention of migraine.
    Durham PL; Garrett FG
    Cephalalgia; 2009 Nov; 29 Suppl 2(Suppl 2):1-6. PubMed ID: 19723120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of tonabersat on migraine with aura: a randomised, double-blind, placebo-controlled crossover study.
    Hauge AW; Asghar MS; Schytz HW; Christensen K; Olesen J
    Lancet Neurol; 2009 Aug; 8(8):718-23. PubMed ID: 19570717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissociation between CSD-Evoked Metabolic Perturbations and Meningeal Afferent Activation and Sensitization: Implications for Mechanisms of Migraine Headache Onset.
    Zhao J; Levy D
    J Neurosci; 2018 May; 38(22):5053-5066. PubMed ID: 29703787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tonabersat inhibits trigeminal ganglion neuronal-satellite glial cell signaling.
    Damodaram S; Thalakoti S; Freeman SE; Garrett FG; Durham PL
    Headache; 2009 Jan; 49(1):5-20. PubMed ID: 19125874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of meningeal nociceptors by cortical spreading depression: implications for migraine with aura.
    Zhang X; Levy D; Noseda R; Kainz V; Jakubowski M; Burstein R
    J Neurosci; 2010 Jun; 30(26):8807-14. PubMed ID: 20592202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tonabersat, a novel gap-junction modulator for the prevention of migraine.
    Silberstein SD
    Cephalalgia; 2009 Nov; 29 Suppl 2():28-35. PubMed ID: 19723123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aura and Head pain: relationship and gaps in the translational models.
    Bolay H; Vuralli D; Goadsby PJ
    J Headache Pain; 2019 Sep; 20(1):94. PubMed ID: 31481015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized, double-blind, placebo-controlled, proof-of-concept study of the cortical spreading depression inhibiting agent tonabersat in migraine prophylaxis.
    Goadsby PJ; Ferrari MD; Csanyi A; Olesen J; Mills JG;
    Cephalalgia; 2009 Jul; 29(7):742-50. PubMed ID: 19222510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aura phenomena do not initiate migraine attacks-Findings from neuroimaging.
    Mehnert J; Fischer-Schulte L; May A
    Headache; 2023 Sep; 63(8):1040-1044. PubMed ID: 37449553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of central trigeminovascular neurons by cortical spreading depression.
    Zhang X; Levy D; Kainz V; Noseda R; Jakubowski M; Burstein R
    Ann Neurol; 2011 May; 69(5):855-65. PubMed ID: 21416489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Migraine: advances in the pathophysiology and treatment].
    Shimizu T; Shibata M; Suzuki N
    Rinsho Shinkeigaku; 2011 Feb; 51(2):103-9. PubMed ID: 21404609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Current views on the pathogenesis of migraine aura].
    Domitrz I
    Neurol Neurochir Pol; 2007; 41(1):70-5. PubMed ID: 17330183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cortical spreading depression and pain: a missing link in the pathophysiology of migraine?].
    Kowa H; Takigawa H; Nakashima K
    Rinsho Shinkeigaku; 2014; 54(12):1006-8. PubMed ID: 25672694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vision and migraine.
    Vincent MB
    Headache; 2015 Apr; 55(4):595-9. PubMed ID: 25758366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Migraine pathophysiology: anatomy of the trigeminovascular pathway and associated neurological symptoms, cortical spreading depression, sensitization, and modulation of pain.
    Noseda R; Burstein R
    Pain; 2013 Dec; 154 Suppl 1():S44-53. PubMed ID: 23891892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cortical spreading depression as a target for anti-migraine agents.
    Costa C; Tozzi A; Rainero I; Cupini LM; Calabresi P; Ayata C; Sarchielli P
    J Headache Pain; 2013 Jul; 14(1):62. PubMed ID: 23879550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. From spreading depression to the trigeminovascular system.
    Dalkara T; Zervas NT; Moskowitz MA
    Neurol Sci; 2006 May; 27 Suppl 2():S86-90. PubMed ID: 16688636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroimaging clues of migraine aura.
    Hadjikhani N; Vincent M
    J Headache Pain; 2019 Apr; 20(1):32. PubMed ID: 30943894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.